In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a ETHYL PARA AMINO BENZOATE Drug Master File in Korea (ETHYL PARA AMINO BENZOATE KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of ETHYL PARA AMINO BENZOATE. The MFDS reviews the ETHYL PARA AMINO BENZOATE KDMF as part of the drug registration process and uses the information provided in the ETHYL PARA AMINO BENZOATE KDMF to evaluate the safety and efficacy of the drug.
After submitting a ETHYL PARA AMINO BENZOATE KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their ETHYL PARA AMINO BENZOATE API can apply through the Korea Drug Master File (KDMF).
click here to find a list of ETHYL PARA AMINO BENZOATE suppliers with KDMF on PharmaCompass.